Crossmark

A mechanistic model of pure and lipidic α-synuclein aggregation for advancing Parkinson’s therapies

Crossref DOI link: https://doi.org/10.1038/s42004-025-01558-3

Published Online: 2025-06-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Righetti, Elena https://orcid.org/0000-0003-2092-4238
Marchetti, Luca https://orcid.org/0000-0001-9043-7705
Domenici, Enrico https://orcid.org/0000-0001-7436-6919
Reali, Federico https://orcid.org/0000-0002-7891-5695
License Information

Text and Data Mining valid from 2025-06-14

Version of Record valid from 2025-06-14
More Information

Article History

Received: 23 September 2024

Accepted: 13 May 2025

First Online: 14 June 2025

Competing interests

: The authors declare no competing interests.